Clin2
NCT07630961Possibly a fitRecruiting

New PET Imaging Scans for Advanced Solid Tumors

Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)Non-small Cell Lung Cancer (NSCLC)HR+/HER2- Ductal Breast Cancer (BC)HR+/HER2- Lobular Breast Cancer (BC)Triple Negative Breast Cancer (TNBC)Colorectal Cancer (CRC)Soft Tissue Sarcoma (STS)

Part of Cancer, Digestive system, Lungs & breathing, Skin clinical trials.

This trial tests two new radioactive imaging scans (called PET scans) designed to better detect certain advanced cancers like pancreatic, lung, breast, colon, or soft-tissue tumors. The goal is to see if these scans help doctors find and track cancer more accurately than standard imaging.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
66 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years old or older
  • You have one of these cancer types: pancreatic, non-small-cell lung, hormone-receptor positive breast, triple-negative breast, colorectal, or soft-tissue sarcoma
  • Your cancer is advanced (cannot be surgically removed or has spread) and you have at least one measurable tumor on CT or MRI
  • Your kidney, liver, and blood cell counts are within acceptable ranges
  • You have a tumor tissue sample (biopsy) available from your medical records
  • You have not had surgery, radiation, or major cancer treatment changes in the past 2 weeks

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07629609Recruiting· Phase 2
New PET scan imaging for pancreatic and stomach cancers

This study tests a new type of PET scan (a detailed imaging test) called [68Ga]Ga-FAPI that may help doctors see cancer better and faster than standard scans. You'll receive this experimental scan to see if it improves cancer detection before surgery.

Copenhagen
NCT06720298Not yet recruiting
New imaging agent for PET scans in cancer

This study tests a new imaging agent that helps PET scans show cancer more clearly. It may help doctors see where cancer is in your body and plan your treatment better.

Beijing, Beijing Municipality
NCT07577206Recruiting· Early Phase 1
New PET Scan Tracer for Advanced Solid Cancers

This early-stage trial tests a new radioactive tracer called [68Ga]Ga-R54 that helps doctors see certain advanced cancers (like breast, lung, colon, ovary, pancreas, or multiple myeloma) on PET scans. The tracer targets a specific protein (CXCR4) found on cancer cells, which may help doctors better detect and understand your cancer.

Naples, Italia
NCT06755086Not yet recruiting
New imaging test for solid tumors

This trial tests a new imaging agent that may help doctors see tumors more clearly during a PET scan. It is for people with certain types of cancer who are willing to have a biopsy of their tumor.

Beijing, Beijing Municipality
NCT06162988Not yet recruiting
A new pet scan for pancreatic, lung, and bowel cancer

This study uses a special PET scan (a type of imaging) to look at tumors in people with pancreatic, lung, or bowel cancer. The scan uses a new tracer that may help doctors see cancer more clearly.

Shanghai
NCT07639801Not yet recruiting
New PET scan for diagnosing solid tumors

This study is testing a new type of PET scan that uses a special tracer to make tumors easier to see. It may help doctors get more accurate information about your tumor before you have a biopsy or surgery.

Hear when a new Colorectal Cancer (CRC) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.